Free Trial

Arrowhead Pharmaceuticals (ARWR) Earnings Date, Estimates & Call Transcripts

Arrowhead Pharmaceuticals logo
$72.69 +0.01 (+0.01%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$72.32 -0.38 (-0.52%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Arrowhead Pharmaceuticals Earnings Summary

Arrowhead Pharmaceuticals posted Q2 2026 earnings on May 7, 2026, reporting an EPS of -$0.93, which beat the consensus estimate of -$1.10 by $0.17. Quarterly revenue fell 86.4% year-over-year to $73.74 million, below analysts' expectations of $73.84 million. With a trailing EPS of -$2.15, Arrowhead Pharmaceuticals' earnings are expected to decrease next year, from ($3.18) to ($3.61) per share.

Latest Q2
Earnings Date
May. 7Estimated
Consensus EPS
(May. 7)
-$1.10
Actual EPS
(May. 7)
-$0.93 Beat By $0.17
Actual Revenue
(May. 7)
$73.74M

Q2 2026 Earnings Resources

Get Arrowhead Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arrowhead Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ARWR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ARWR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arrowhead Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261$1.63$1.63$1.63
Q2 20262-$1.29-$0.98-$1.14
Q3 20262-$1.49-$1.02-$1.26
Q4 20262-$1.51-$1.03-$1.27
FY 2026 7 -$2.66 -$1.40 -$2.03
Q1 20271-$1.03-$1.03-$1.03
Q2 20271-$1.24-$1.24-$1.24
Q3 20271-$1.25-$1.25-$1.25
Q4 20271$0.13$0.13$0.13

Arrowhead Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2026Q2 2026-$1.0950-$0.93+$0.1650-$0.93$73.84M$73.74M
2/5/2026Q1 2026$0.60$0.22 -$0.38$0.22$225.66M$264.03M
8/7/2025Q3 2025-$0.94-$1.26 -$0.32-$1.26$29.01M$27.77M
5/12/2025Q2 2025-$0.06$2.75+$2.81$2.75$116.27M$542.71M
2/10/2025Q1 2025-$0.42-$1.39 -$0.97-$1.39$19.05M-
8/8/2024Q3 2024-$0.58-$1.38 -$0.80-$1.38$52.87M-

Data powered by Fiscal.ai.

Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions

Arrowhead Pharmaceuticals (NASDAQ:ARWR) last announced its quarterly earning data on Thursday, May 7, 2026. Learn more on ARWR's earnings history.

In the previous quarter, Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported ($0.93) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.10) by $0.17. Learn more on analysts' earnings estimate vs. ARWR's actual earnings.

The conference call for Arrowhead Pharmaceuticals' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Arrowhead Pharmaceuticals' latest earnings report can be read online.
Read Transcript

Arrowhead Pharmaceuticals' earnings report can be found in their filing with the SEC.
View SEC filing

Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded annual revenue of $829.45 million.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded net income of -$1.63 million. ARWR has generated -$2.15 earnings per share over the last four quarters.

Arrowhead Pharmaceuticals' earnings are expected to decrease from ($3.18) per share to ($3.61) per share in the next year.


This page (NASDAQ:ARWR) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners